Koselugo (selumetinib)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Koselugo (selumetinib), covering 2026-04-13 to 2026-04-13. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Compare Treatment With the Drug Selumetinib Alone Versus Selumetinib and Vinblastine in Patients With Recurrent or Progressive Low-Grade Glioma [Phase 3]